Water T2 could predict functional decline in patients with dysferlinopathy.

Area of Science:

• Biomedical Imaging
• Neuromuscular Disorders
• Clinical Trials

Background:

• Water T2 (T2_H2O) mapping assesses active muscle damage in muscular dystrophies.
• T2_H2O is a potential surrogate outcome measure for clinical trials.

Purpose of the Study:

• Investigate the prognostic utility of T2_H2O for muscle function changes in limb girdle muscular dystrophies.
• Assess if baseline T2_H2O predicts functional decline over time in dysferlinopathy patients.

Main Methods:

• Assessed 18 dysferlinopathy patients using 3-tesla MRI.
• Defined T2_H2O as higher or lower than the median in each muscle.
• Analyzed functional test deterioration over 3 years against baseline T2_H2O, age, disease duration, and function.

Main Results:

• Higher baseline T2_H2O correlated with greater functional decline in 21/35 muscles.
• Specific muscles (adductor magnus, vasti) showed significant associations with decline.
• Patients with higher T2_H2O in vastus medialis had significantly worse outcomes on key functional tests.

Conclusions:

• Baseline T2_H2O predicts faster functional decline in dysferlinopathy.
• T2_H2O may explain inter-patient differences in disease progression.
• Standardization of T2_H2O across sites is needed for global applicability in clinical trials.